TELA TELA Bio, Inc. Stock Quote

TELA [NASD]

Index	-	P/E	-	EPS (ttm)	-2.21	Insider Own	7.33%	Shs Outstand	14.46M	Perf Week	-0.47%
Market Cap	185.93M	Forward P/E	-	EPS next Y	-1.70	Insider Trans	37.93%	Shs Float	12.80M	Perf Month	-6.75%
Income	-31.90M	PEG	-	EPS next Q	-0.53	Inst Own	89.60%	Short Float	0.63%	Perf Quarter	-17.10%
Sales	24.40M	P/S	7.62	EPS this Y	15.90%	Inst Trans	1.86%	Short Ratio	4.72	Perf Half Y	-6.34%
Book/sh	2.42	P/B	5.25	EPS next Y	23.10%	ROA	-38.50%	Target Price	-	Perf Year	-20.63%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-70.10%	52W Range	11.03 - 18.00	Perf YTD	-15.56%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-31.70%	52W High	-29.44%	Beta	-
Dividend %	-	Quick Ratio	9.10	Sales past 5Y	-	Gross Margin	63.50%	52W Low	15.14%	ATR	0.51
Employees	108	Current Ratio	9.70	Sales Q/Q	117.10%	Oper. Margin	-	RSI (14)	45.71	Volatility	2.02% 4.26%
Optionable	No	Debt/Eq	0.89	EPS Q/Q	-7.40%	Profit Margin	-	Rel Volume	0.14	Prev Close	12.60
Shortable	Yes	LT Debt/Eq	0.89	Earnings	Aug 11 AMC	Payout	-	Avg Volume	16.96K	Price	12.70
Recom	1.50	SMA20	-1.81%	SMA50	-3.38%	SMA200	-10.29%	Volume	2,329	Change	0.79%

Dec-03-19

Initiated

Piper Jaffray

Overweight

Dec-03-19

Initiated

JMP Securities

Mkt Outperform

Dec-03-19

Initiated

Jefferies

Buy

Dec-03-19

Initiated

Canaccord Genuity

Buy

Sep-27-21 07:00AM	TELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer GlobeNewswire
Sep-24-21 09:33AM	10 Best Healthcare Stocks to Buy According to Matthew Halbowers Pentwater Capital Management Insider Monkey
Sep-13-21 07:00AM	TELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique GlobeNewswire
Sep-09-21 10:35AM	Is TELA Bio (NASDAQ:TELA) Using Too Much Debt? Simply Wall St.
Aug-16-21 07:00AM	TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021 GlobeNewswire
Aug-11-21 11:00PM	TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript Motley Fool
05:35PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand GlobeNewswire
Aug-04-21 03:00PM	TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Aug-03-21 07:00AM	TELA Bio to Participate in Canaccord Genuitys 41st Annual Growth Conference GlobeNewswire
Jul-28-21 07:00AM	TELA Bio to Announce Second Quarter 2021 Financial Results GlobeNewswire
Jul-21-21 08:28AM	NHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix GlobeNewswire
Jun-18-21 10:47AM	New Strong Sell Stocks for June 18th Zacks
Jun-14-21 07:00AM	TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference GlobeNewswire
Jun-02-21 07:00AM	TELA Bio Announces Changes to its Board of Directors GlobeNewswire
06:34AM	TELA Bio's (NASDAQ:TELA) Shareholders Are Down 22% On Their Shares Simply Wall St.
May-25-21 07:00AM	TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs GlobeNewswire
May-21-21 07:00AM	TELA Bio to Participate in Upcoming Investor Conferences GlobeNewswire
May-19-21 07:00AM	TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias GlobeNewswire
May-14-21 06:30AM	TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript Motley Fool +6.24%
May-13-21 06:15PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:02PM	TELA Bio Announces First Quarter 2021 Financial Results GlobeNewswire
02:30PM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
May-06-21 03:01PM	TELA Bio, Inc. (TELA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
May-03-21 11:48AM	TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript Motley Fool
Apr-29-21 04:00PM	TELA Bio to Announce First Quarter 2021 Financial Results GlobeNewswire
Mar-24-21 05:25PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:28PM	Recap: TELA Bio Q4 Earnings Benzinga
04:01PM	TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
02:30PM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
Mar-18-21 07:00AM	TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair GlobeNewswire
Mar-02-21 07:00AM	TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021 GlobeNewswire
Feb-12-21 05:16AM	Is TELA Bio (NASDAQ:TELA) Using Too Much Debt? Simply Wall St.
Feb-04-21 07:00AM	TELA Bio to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference GlobeNewswire
Jan-14-21 07:00AM	TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020 GlobeNewswire
Jan-06-21 07:00AM	TELA Bio to Participate in Upcoming Needham Virtual Growth Conference GlobeNewswire
Jan-05-21 07:00AM	TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development GlobeNewswire
Dec-09-20 01:32PM	Is TELA A Good Stock To Buy Now? Insider Monkey
Nov-24-20 07:00AM	TELA Bio to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
Nov-11-20 04:34PM	Recap: TELA Bio Q3 Earnings Benzinga
04:05PM	TELA Bio Announces Third Quarter 2020 Financial Results GlobeNewswire
02:30PM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
Nov-10-20 07:00AM	TELA Bio to Participate at Upcoming Investor Conferences GlobeNewswire
Oct-21-20 04:05PM	TELA Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call on November 11, 2020 GlobeNewswire
Sep-25-20 07:00AM	TELA Bio Presents Additional Data from BRAVO Study of OviTex® for Ventral Hernia Repair GlobeNewswire
Sep-02-20 07:00AM	TELA Bio to Participate at Upcoming Conferences GlobeNewswire -5.24%
Aug-12-20 04:05PM	TELA Bio Announces Second Quarter 2020 Financial Results GlobeNewswire
07:29AM	The Daily Biotech Pulse: India Globalization Gets Nod For Alzheimer's Trial, Moderna's Vaccine Deal With US, Cellular Biomedicine To Go Private Benzinga
Jul-30-20 07:00AM	TELA Bio to Participate at the Canaccord Genuity 40th Annual Growth Conference GlobeNewswire
Jul-23-20 05:19PM	TELA Bio to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 12, 2020 GlobeNewswire
Jun-30-20 04:05PM	TELA Bio Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-25-20 06:42PM	TELA Bio Announces Pricing of Public Offering of Common Stock GlobeNewswire -8.14%
Jun-24-20 08:07AM	The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact Benzinga -6.58%
Jun-23-20 09:35PM	Hedge Funds Cautiously Watching TELA Bio, Inc. (TELA) Insider Monkey
04:17PM	TELA Bio Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-22-20 07:00AM	TELA Bio, Inc. to Join the Russell 2000® Index GlobeNewswire -7.56%
Jun-15-20 07:00AM	TELA Bio, Inc. Announces Poster Presentations at the 2020 Minimally Invasive Surgery Symposium (MISS) GlobeNewswire +8.42%
May-29-20 07:00AM	TELA Bio to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-12-20 04:05PM	TELA Bio Announces First Quarter 2020 Financial Results GlobeNewswire -10.27%
Apr-28-20 07:00AM	TELA Bio to Announce First Quarter 2020 Financial Results and Host Conference Call on May 12, 2020 GlobeNewswire -12.19%
Apr-23-20 06:30AM	TELA Bio Announces Changes to its Board of Directors GlobeNewswire
Mar-30-20 07:29AM	TELA Bio, Inc. (NASDAQ:TELA) Just Reported And Analysts Have Been Cutting Their Estimates Simply Wall St.
Mar-27-20 07:00AM	TELA Bio Announces Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
06:00AM	TELA Bio Inc to Host Earnings Call ACCESSWIRE
Mar-11-20 07:00AM	TELA Bio to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 27, 2020 GlobeNewswire -13.39%
Feb-04-20 04:15PM	TELA Bio Announces Publication of Results from In-Vivo Study Demonstrating Favorable Response to Reinforced Biologics in Hernia Repair GlobeNewswire
Jan-29-20 07:00AM	TELA Bio Announces Appointment of New Chief Commercial Officer GlobeNewswire
Jan-10-20 07:00AM	TELA Bio Announces Preliminary Revenue for Fourth Quarter and Full Year 2019 GlobeNewswire
Dec-18-19 07:00AM	TELA Bio Announces Third Quarter 2019 Financial Results GlobeNewswire +11.46%
Dec-06-19 07:00AM	TELA Bio Awarded Contract with HealthTrust Purchasing Group GlobeNewswire
Nov-13-19 04:15PM	TELA Bio Appoints Federica OBrien to Board of Directors GlobeNewswire
04:05PM	TELA Bio Announces Closing of Initial Public Offering of Common Stock GlobeNewswire
Nov-08-19 06:17PM	Chinese Tech News Site 36Kr Flops in Tough Week for U.S. IPOs Bloomberg
Nov-07-19 08:00PM	TELA Bio Announces Pricing of Initial Public Offering of Common Stock GlobeNewswire

TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EW HEALTHCARE PARTNERS FUND 2,		Oct 13	Buy	12.50	200	2,500	1,834,582	Oct 13 06:20 PM
EW HEALTHCARE PARTNERS FUND 2,		Oct 11	Buy	12.50	283	3,538	1,834,382	Oct 13 06:20 PM
EW HEALTHCARE PARTNERS FUND 2,		Oct 06	Buy	12.50	110	1,375	1,834,099	Oct 08 12:57 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 21	Buy	12.60	695	8,757	1,833,989	Sep 23 06:38 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 20	Buy	12.58	924	11,624	1,833,294	Sep 21 05:41 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 17	Buy	12.61	322	4,060	1,832,370	Sep 21 05:41 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 14	Buy	12.27	10,000	122,700	1,822,048	Sep 15 01:23 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 13	Buy	12.43	115	1,429	1,812,048	Sep 15 01:23 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 13	Buy	12.43	10,000	124,300	1,832,048	Sep 17 04:52 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 10	Buy	12.31	14,436	177,707	1,811,933	Sep 13 02:55 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 09	Buy	12.46	13,087	163,064	1,797,497	Sep 13 02:55 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 08	Buy	13.24	47	622	1,784,410	Sep 09 01:36 PM
EW HEALTHCARE PARTNERS FUND 2,		Sep 07	Buy	12.77	131	1,673	1,784,363	Sep 09 01:36 PM
EW HEALTHCARE PARTNERS FUND 2,		Jun 14	Buy	12.50	79,970	999,625	1,784,232	Jun 16 12:17 PM
EW HEALTHCARE PARTNERS FUND 2,		Jun 07	Buy	12.99	10,000	129,900	1,704,262	Jun 09 08:20 PM
EW HEALTHCARE PARTNERS FUND 2,		Jun 03	Buy	13.17	201	2,647	1,694,262	Jun 07 04:42 PM
EW HEALTHCARE PARTNERS FUND 2,		May 24	Buy	13.31	1,278	17,010	1,694,061	May 27 03:11 PM
EW HEALTHCARE PARTNERS FUND 2,		May 21	Buy	13.30	1,549	20,602	1,692,783	May 27 03:11 PM
EW HEALTHCARE PARTNERS FUND 2,		May 20	Buy	13.30	8,525	113,382	1,691,234	May 20 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		May 19	Buy	13.44	450	6,048	1,682,709	May 20 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		May 18	Buy	13.30	3,546	47,162	1,682,259	May 20 07:01 PM
EW HEALTHCARE PARTNERS FUND 2,		May 14	Buy	13.08	5,658	74,007	1,678,713	May 18 05:06 PM
EW HEALTHCARE PARTNERS FUND 2,		May 14	Buy	12.45	7,500	93,375	1,673,055	May 18 05:00 PM
EW HEALTHCARE PARTNERS FUND 2,		May 11	Buy	12.75	7,500	95,625	1,650,555	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		May 10	Buy	12.93	7,500	96,975	1,643,055	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		May 07	Buy	13.15	7,500	98,625	1,635,555	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		May 06	Buy	13.15	6,499	85,462	1,628,055	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		May 05	Buy	13.28	7,500	99,600	1,621,556	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 28	Buy	13.41	200	2,682	1,614,056	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 27	Buy	13.49	15,000	202,350	1,613,856	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 23	Buy	13.51	5,000	67,550	1,598,856	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 22	Buy	13.54	5,000	67,700	1,593,856	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 21	Buy	13.59	365	4,960	1,588,856	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 20	Buy	13.54	4,678	63,340	1,588,491	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 19	Buy	13.61	625	8,506	1,583,813	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 12	Buy	13.57	2,893	39,258	1,583,188	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Apr 08	Buy	13.67	206	2,816	1,580,295	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 26	Buy	12.88	37,851	487,521	1,580,089	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 25	Buy	13.11	5,000	65,550	1,542,238	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 24	Buy	13.94	2,660	37,080	1,537,238	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Mar 23	Buy	13.79	10,000	137,900	1,534,578	May 13 04:49 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 04	Buy	14.29	2,822	40,326	1,524,578	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 02	Buy	14.08	250	3,520	1,521,756	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Feb 01	Buy	14.16	1,119	15,845	1,521,506	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 29	Buy	13.93	7,760	108,097	1,520,387	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 28	Buy	13.68	13,950	190,836	1,512,627	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 27	Buy	14.03	5,000	70,150	1,498,677	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 26	Buy	14.24	1,544	21,987	1,493,677	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 15	Buy	13.88	763	10,590	1,492,133	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 14	Buy	13.96	9,075	126,687	1,491,370	Feb 23 12:47 PM
EW HEALTHCARE PARTNERS FUND 2,		Jan 13	Buy	13.90	7,002	97,328	1,482,295	Feb 23 12:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience